This is a U.S. news story, published by KFF Health News, that relates primarily to Ann Lewandowski news.
For more U.S. news, you can click here:
more U.S. newsFor more Ann Lewandowski news, you can click here:
more Ann Lewandowski newsFor more health policy news, you can click here:
more health policy newsFor more news from KFF Health News, you can click here:
more news from KFF Health NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about health policy, you might also like this article about
expensive multiple sclerosis drug. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest pharmacy benefit managers news, PBM contracts news, news about health policy, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
drug benefit plansKFF Health News
•
80% Informative
Ann Lewandowski , a former policy advocate at Johnson & Johnson , filed a lawsuit against Express Scripts .
She says the company failed in its duty to ensure reasonable drug prices for its 50,000 U.S. employees.
In recent years , the opaque business practices of PBMs have drawn fire.
The Federal Trade Commission is conducting a lengthy investigation of the three biggest companies.
Critics say they are skimming up to 25% from the drug market, perhaps $100 billion a year.
Cost Plus generates the biggest savings for its customers on about 50 extraordinarily high-priced generic drugs.
The ERISA Industry Committee is asking Congress to give PBMs the specific duty to represent their clients’ financial interests.
Sen. Bernie Sanders grilled Novo Nordisk CEO Lars Fruergaard Jørgensen over high prices for diabetes and weight loss drugs Ozempic and Wegovy .
The executive expressed support for a more transparent pricing model.
“I think patients would be significantly better off,” he said.
VR Score
82
Informative language
82
Neutral language
38
Article tone
semi-formal
Language
English
Language complexity
47
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
4
Source diversity
4
Affiliate links
no affiliate links